• Citer

Precision oncology: as much expectations as limitations.

par Vasconcellos, Vitor Fiorin;Colli, Leandro Machado;Awada, Ahmad ;de Castro Junior, Gilberto
Référence ecancermedicalscience, 12, page (ed86)
Publication Publié, 2018

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Résumé :

It is encouraging to witness the recent price reduction and expanded access to next generation sequencing platforms, the increasing number of investments and publications on new targets and respective targeted drugs, as well as the worldwide excitement with anti-cancer personalised therapies. This editorial aims to highlight the limitations regarding the small proportion of solid cancers potentially eligible for the use of molecular-based targeted drugs until now. It also covers the expected clinical benefits in refractory patients treated by matched therapies, and detailed cost-effectiveness analysis of the use of DNA sequencing analysis oncology practice in an academic and large-scale community.